Richard Binstein - Mar 2, 2023 Form 4 Insider Report for U S PHYSICAL THERAPY INC /NV (USPH)

Role: EVP Gen'l Counsel & Secretary
Signature: /s/ Richard S Binstein
Stock symbol: USPH
Transactions as of: Mar 2, 2023
Transactions value $: -$91,811
Form type: 4
Date filed: 3/3/2023, 09:20 AM
Previous filing: Feb 23, 2023
Next filing: Aug 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USPH	Common Stock	Sale	-$91.8K	-911	-8.42%	$100.78	9.91K	Mar 2, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.71 to $100.90, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2	Includes 9,906 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 968 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, and on January 1, 2024; 733 shares on each of April 1, 2024, July 1,2024, and October 1, 2024; 734 shares on January 1, 2025; 539 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 542 shares on January 1, 2026 and 234 shares on April 1, 2026, if he is an employee of the Company on those dates.

Content

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.71 to $100.90, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Includes 9,906 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 968 shares on each of April 1, 2023, July 1, 2023, October 1, 2023, and on January 1, 2024; 733 shares on each of April 1, 2024, July 1,2024, and October 1, 2024; 734 shares on January 1, 2025; 539 shares on each of April 1, 2025, July 1, 2025 and October 1, 2025; 542 shares on January 1, 2026 and 234 shares on April 1, 2026, if he is an employee of the Company on those dates.